{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-017882","form_type":"8-K","ticker":"MD","cik":"0000893949","company_name":"Pediatrix Medical Group, Inc.","filed_at":"2023-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.684757+00:00","generated_at":"2026-06-15T23:49:14.426472+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Pediatrix appoints Sylvia Young as independent director effective May 12","bullets":["Board size increased to nine; Ms. Young appointed as independent director.","Young recently served as President/CEO of HCA Continental Division, retired March 2023.","She will receive standard non-employee director compensation and enter indemnification agreement.","No material transactions or arrangements with Young; no committee assignments yet.","Appointment effective May 12, 2023; press release issued May 4."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-017882","json":"https://secwatch.observer/filing/0000950170-23-017882.json","markdown":"https://secwatch.observer/filing/0000950170-23-017882.md","text":"https://secwatch.observer/filing/0000950170-23-017882.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/893949/000095017023017882/0000950170-23-017882-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/893949/000095017023017882/md-20230504.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T23:49:14.426472+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"44706c6f41","claim":"Sylvia Young was appointed as Director at Pediatrix Medical Group, Inc..","evidence_excerpt":"increased the size of the Company’s Board to nine (9) members and appointed Ms. Sylvia Young to serve as a Director of the Company, each effective as of May 12, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/893949/000095017023017882/0000950170-23-017882-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}